- Home
- FTHM vs VRCA Comparison
FTHM vs VRCA Comparison
Compare FTHM & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FTHM | VRCA |
|---|---|---|
| Founded | 2010 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.9M | 32.7M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | FTHM | VRCA |
|---|---|---|
| Price | $1.12 | $8.29 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | 115.2K | ★ 402.7K |
| Earning Date | 11-11-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $421,612,000.00 | $30,829,000.00 |
| Revenue This Year | $30.07 | $373.65 |
| Revenue Next Year | $14.66 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 32.78 | ★ 234.73 |
| 52 Week Low | $0.65 | $3.28 |
| 52 Week High | $3.37 | $9.82 |
Technical Indicators
Market Signals| Indicator | FTHM | VRCA |
|---|---|---|
| Relative Strength Index (RSI) | 40.46 | 64.48 |
| Support Level | $1.16 | $7.82 |
| Resistance Level | $1.27 | $9.78 |
| Average True Range (ATR) | 0.07 | 1.17 |
| MACD | 0.02 | 0.06 |
| Stochastic Oscillator | 9.09 | 69.53 |
Price Performance
Historical ComparisonAbout FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.